|
|
Other links at Articles > Business of Medicine |
| 1. |
Less Medicare Pain Seen for U.S. Nursing Homes
|
|
|
Nursing home stocks could get a bounce next week if feared cuts worth billions of dollars to their reimbursement rates under the U.S. Medicare insurance program for the elderly are softened. Reuters Health Information
|
| 3. |
MAP Pharma Gets FDA Nod on Migraine Study Protocol
|
|
|
MAP Pharmaceuticals said it reached an agreement with the U.S. Food and Drug Administration on the protocol for the first late-stage clinical trial of its migraine treatment, MAP0004. Reuters Health Information
|
| 5. |
More Heparin Recalls in Europe and US
|
|
|
The latest countries to recall heparin products are France, Italy, and Denmark, and the affected material has been traced to four Chinese suppliers. Another US manufacturer has also recalled some heparin products. Heartwire
|
|
|
